TotalMarketCap

Bio-Techne

TECHNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$11.400 B

$72.70 -0.05%

Close of 6 Nov 2026

As of 6 Nov 2026, Bio-Techne (TECH) has a market capitalization of $11.4B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.22B

#1408 by revenue

Earnings

$73.4M

#1413 by earnings

Shares outstanding

157,055,564

Latest filing cover page

P/E ratio

155.3

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #9Neurocrine BiosciencesNBIX$16.2B
  2. #10Halozyme TherapeuticsHALO$14.0B
  3. #11Bio-TechneTECH$11.4B
  4. #12Kymera TherapeuticsKYMR$10.8B
  5. #13RepligenRGEN$10.8B

What if Bio-Techne were worth as much as…

Open the what-if tool →

Gold $28.2T

$180,061.16

Per share 2,477× higher

Bitcoin $1.53T

$9,742.80

Per share 134× higher

Apple $5.02T

$31,984.69

Per share 440× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Bio-Techne are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.